• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EClinicalMedicine . Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19

tetano

Editor, Senior Moderator
EClinicalMedicine


. 2022 Jun;48:101438.
doi: 10.1016/j.eclinm.2022.101438. Epub 2022 May 14.
Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19


Richard Dannebaum[SUP] 1 [/SUP], Phillip Suwalski[SUP] 2 [/SUP], Hosseinali Asgharian[SUP] 1 [/SUP], Gracie Du Zhipei[SUP] 1 [/SUP], Hai Lin[SUP] 1 [/SUP], January Weiner[SUP] 3 [/SUP], Manuel Holtgrewe[SUP] 3 [/SUP], Charlotte Thibeault[SUP] 4 [/SUP], Melina Müller[SUP] 2 [/SUP], Xiaomin Wang[SUP] 2 [/SUP], Zehra Karadeniz[SUP] 2 [/SUP], Jacopo Saccomanno[SUP] 4 [/SUP], Jan-Moritz Doehn[SUP] 4 [/SUP], Ralf-Harto Hübner[SUP] 4 [/SUP], Bernd Hinzmann[SUP] 5 [/SUP], Anja Blüher[SUP] 5 [/SUP], Sandra Siemann[SUP] 5 [/SUP], Dilduz Telman[SUP] 1 [/SUP], Norbert Suttorp[SUP] 4 [/SUP], Martin Witzenrath[SUP] 4 [/SUP], Stefan Hippenstiel[SUP] 4 [/SUP], Carsten Skurk[SUP] 2 [/SUP], Wolfgang Poller[SUP] 2 [/SUP], Leif E Sander[SUP] 4 [/SUP], Dieter Beule[SUP] 3 [/SUP], Florian Kurth[SUP] 4 [/SUP], Toumy Guettouche[SUP] 1 [/SUP], Ulf Landmesser[SUP] 2 6 [/SUP], Jan Berka[SUP] 1 [/SUP], Khai Luong[SUP] 1 [/SUP], Pa-COVID Study Group; Florian Rubelt[SUP] 1 [/SUP], Bettina Heidecker[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics can be characterized by deciphering the adaptive immune response.
Methods: In this cross-sectional study we analyzed 117 peripheral blood immune repertoires from healthy controls and subjects with mild to severe COVID-19 disease to elucidate the interplay between B and T cells. We used an immune repertoire Primer Extension Target Enrichment method (immunoPETE) to sequence simultaneously human leukocyte antigen (HLA) restricted T cell receptor beta chain (TRB) and unrestricted T cell receptor delta chain (TRD) and immunoglobulin heavy chain (IgH) immune receptor repertoires. The distribution was analyzed of TRB, TRD and IgH clones between healthy and COVID-19 infected subjects. Using McFadden's Adjusted R2 variables were examined for a predictive model. The aim of this study is to analyze the influence of the adaptive immune repertoire on the severity of the disease (value on the World Health Organization Clinical Progression Scale) in COVID-19.
Findings: Combining clinical metadata with clonotypes of three immune receptor heavy chains (TRB, TRD, and IgH), we found significant associations between COVID-19 disease severity groups and immune receptor sequences of B and T cell compartments. Logistic regression showed an increase in shared IgH clonal types and decrease of TRD in subjects with severe COVID-19. The probability of finding shared clones of TRD clonal types was highest in healthy subjects (controls). Some specific TRB clones seems to be present in severe COVID-19 (Figure S7b). The most informative models (McFadden´s Adjusted R2=0.141) linked disease severity with immune repertoire measures across all three cell types, as well as receptor-specific cell counts, highlighting the importance of multiple lymphocyte classes in disease progression.
Interpretation: Adaptive immune receptor peripheral blood repertoire measures are associated with COVID-19 disease severity.
Funding: The study was funded with grants from the Berlin Institute of Health (BIH).

Keywords: COVID-19; Clinical course; Immune receptor; Immune repertoires.
 
Back
Top Bottom